NDSI
Newman Dignan & Sheerar Inc’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-287
| Closed | -$182K | – | 200 |
|
|
2025
Q1 | $182K | Sell |
287
-25
| -8% | -$15.9K | 0.05% | 161 |
|
|
2024
Q4 | $222K | Sell |
312
-60
| -16% | -$42.7K | 0.06% | 164 |
|
|
2024
Q3 | $345K | Buy |
372
+61
| +20% | +$56.6K | 0.08% | 138 |
|
|
2024
Q2 | $327K | Sell |
311
-167
| -35% | -$176K | 0.08% | 138 |
|
|
2024
Q1 | $460K | Sell |
478
-70
| -13% | -$67.4K | 0.12% | 120 |
|
|
2023
Q4 | $481K | Buy |
548
+55
| +11% | +$48.3K | 0.15% | 114 |
|
|
2023
Q3 | $406K | Sell |
493
-45
| -8% | -$37K | 0.13% | 118 |
|
|
2023
Q2 | $387K | Sell |
538
-40
| -7% | -$28.7K | 0.12% | 124 |
|
|
2023
Q1 | $475K | Sell |
578
-40
| -6% | -$32.9K | 0.15% | 114 |
|
|
2022
Q4 | $446K | Sell |
618
-62
| -9% | -$44.7K | 0.15% | 118 |
|
|
2022
Q3 | $468 | Sell |
680
-5
| -0.7% | -$3 | 0.07% | 111 |
|
|
2022
Q2 | $405K | Buy |
685
+5
| +0.7% | +$2.96K | 0.14% | 124 |
|
|
2022
Q1 | $475 | Sell |
680
-137
| -17% | -$96 | 0.09% | 115 |
|
|
2021
Q4 | $516K | Buy |
+817
| New | +$516K | 0.16% | 113 |
|
|
2016
Q1 | – | Sell |
-411
| Closed | -$223K | – | 138 |
|
|
2015
Q4 | $223K | Buy |
+411
| New | +$223K | 0.16% | 133 |
|
|
2015
Q3 | – | Sell |
-526
| Closed | -$268K | – | 146 |
|
|
2015
Q2 | $268K | Sell |
526
-25
| -5% | -$12.7K | 0.19% | 123 |
|
|
2015
Q1 | $249K | Sell |
551
-25
| -4% | -$11.3K | 0.18% | 127 |
|
|
2014
Q4 | $236 | Hold |
576
| – | – | 0.14% | 132 |
|
|
2014
Q3 | $208K | Buy |
+576
| New | +$208K | 0.16% | 137 |
|